Preference-weighted health-related quality of life measures and substance use disorder severity

Jeffrey M. Pyne, Michael French, Kathryn McCollister, Shanti Tripathi, Richard Rapp, Brenda Booth

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Aims: Examine the validity of preference-weighted health-related quality of life measures in a sample of substance use disorder (SUD) patients. The implications of cost-utility analyses (CUAs) of SUD interventions are discussed. Design: Cross-sectional analysis of subjects seeking SUD treatment. Setting: Seven SUD treatment centers in a medium-sized Midwestern metropolitan area in the United States. Participants: Data from 574 SUD subjects were analyzed from a study to test interventions to improve linkage and engagement with substance abuse treatment. Measurements: Subjects completed the following preference-weighted measures: self-administered Quality of Well-Being scale (QWB-SA) and Medical Outcomes Study SF-12 (standard gamble weighted or SF-12 SG); and clinical measures: Addiction Severity Index (ASI) and a symptom checklist based on the DSM-IV. Findings: In unadjusted analyses, the QWB-SA was correlated significantly with six of seven ASI subscales and the SF-12 SG was correlated with four of seven. In adjusted analyses, both preference-weighted measures were significantly correlated with diagnostic, physical health, mental health and drug use measures, but not with legal or alcohol use measures. The QWB-SA was also correlated with employment problems and the SF-12 SG was correlated with family/social problems. Conclusions: This study generally supports the construct validity of preference-weighted health-related quality of life measures in SUD patients. However, the QWB-SA and SF-12 SG did not correlate with all ASI scales. Cost-benefit analysis may be preferable when policy-makers are interested in evaluating the full range of SUD intervention outcomes.

Original languageEnglish
Pages (from-to)1320-1329
Number of pages10
JournalAddiction
Volume103
Issue number8
DOIs
StatePublished - Aug 1 2008

Fingerprint

Substance-Related Disorders
Quality of Life
Cost-Benefit Analysis
Social Problems
Administrative Personnel
Checklist
Diagnostic and Statistical Manual of Mental Disorders
Mental Health
Therapeutics
Cross-Sectional Studies
Alcohols
Outcome Assessment (Health Care)
Health
Pharmaceutical Preparations

Keywords

  • Cost-effectiveness analysis
  • Cost-utility analysis
  • Health-related quality of life
  • Quality of wellbeing scale
  • SF-12 scale
  • Substance use disorder

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Preference-weighted health-related quality of life measures and substance use disorder severity. / Pyne, Jeffrey M.; French, Michael; McCollister, Kathryn; Tripathi, Shanti; Rapp, Richard; Booth, Brenda.

In: Addiction, Vol. 103, No. 8, 01.08.2008, p. 1320-1329.

Research output: Contribution to journalArticle

Pyne, Jeffrey M. ; French, Michael ; McCollister, Kathryn ; Tripathi, Shanti ; Rapp, Richard ; Booth, Brenda. / Preference-weighted health-related quality of life measures and substance use disorder severity. In: Addiction. 2008 ; Vol. 103, No. 8. pp. 1320-1329.
@article{410dca3553ad4cc3932dda65bef6e2a0,
title = "Preference-weighted health-related quality of life measures and substance use disorder severity",
abstract = "Aims: Examine the validity of preference-weighted health-related quality of life measures in a sample of substance use disorder (SUD) patients. The implications of cost-utility analyses (CUAs) of SUD interventions are discussed. Design: Cross-sectional analysis of subjects seeking SUD treatment. Setting: Seven SUD treatment centers in a medium-sized Midwestern metropolitan area in the United States. Participants: Data from 574 SUD subjects were analyzed from a study to test interventions to improve linkage and engagement with substance abuse treatment. Measurements: Subjects completed the following preference-weighted measures: self-administered Quality of Well-Being scale (QWB-SA) and Medical Outcomes Study SF-12 (standard gamble weighted or SF-12 SG); and clinical measures: Addiction Severity Index (ASI) and a symptom checklist based on the DSM-IV. Findings: In unadjusted analyses, the QWB-SA was correlated significantly with six of seven ASI subscales and the SF-12 SG was correlated with four of seven. In adjusted analyses, both preference-weighted measures were significantly correlated with diagnostic, physical health, mental health and drug use measures, but not with legal or alcohol use measures. The QWB-SA was also correlated with employment problems and the SF-12 SG was correlated with family/social problems. Conclusions: This study generally supports the construct validity of preference-weighted health-related quality of life measures in SUD patients. However, the QWB-SA and SF-12 SG did not correlate with all ASI scales. Cost-benefit analysis may be preferable when policy-makers are interested in evaluating the full range of SUD intervention outcomes.",
keywords = "Cost-effectiveness analysis, Cost-utility analysis, Health-related quality of life, Quality of wellbeing scale, SF-12 scale, Substance use disorder",
author = "Pyne, {Jeffrey M.} and Michael French and Kathryn McCollister and Shanti Tripathi and Richard Rapp and Brenda Booth",
year = "2008",
month = "8",
day = "1",
doi = "10.1111/j.1360-0443.2008.02153.x",
language = "English",
volume = "103",
pages = "1320--1329",
journal = "Addiction",
issn = "0965-2140",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Preference-weighted health-related quality of life measures and substance use disorder severity

AU - Pyne, Jeffrey M.

AU - French, Michael

AU - McCollister, Kathryn

AU - Tripathi, Shanti

AU - Rapp, Richard

AU - Booth, Brenda

PY - 2008/8/1

Y1 - 2008/8/1

N2 - Aims: Examine the validity of preference-weighted health-related quality of life measures in a sample of substance use disorder (SUD) patients. The implications of cost-utility analyses (CUAs) of SUD interventions are discussed. Design: Cross-sectional analysis of subjects seeking SUD treatment. Setting: Seven SUD treatment centers in a medium-sized Midwestern metropolitan area in the United States. Participants: Data from 574 SUD subjects were analyzed from a study to test interventions to improve linkage and engagement with substance abuse treatment. Measurements: Subjects completed the following preference-weighted measures: self-administered Quality of Well-Being scale (QWB-SA) and Medical Outcomes Study SF-12 (standard gamble weighted or SF-12 SG); and clinical measures: Addiction Severity Index (ASI) and a symptom checklist based on the DSM-IV. Findings: In unadjusted analyses, the QWB-SA was correlated significantly with six of seven ASI subscales and the SF-12 SG was correlated with four of seven. In adjusted analyses, both preference-weighted measures were significantly correlated with diagnostic, physical health, mental health and drug use measures, but not with legal or alcohol use measures. The QWB-SA was also correlated with employment problems and the SF-12 SG was correlated with family/social problems. Conclusions: This study generally supports the construct validity of preference-weighted health-related quality of life measures in SUD patients. However, the QWB-SA and SF-12 SG did not correlate with all ASI scales. Cost-benefit analysis may be preferable when policy-makers are interested in evaluating the full range of SUD intervention outcomes.

AB - Aims: Examine the validity of preference-weighted health-related quality of life measures in a sample of substance use disorder (SUD) patients. The implications of cost-utility analyses (CUAs) of SUD interventions are discussed. Design: Cross-sectional analysis of subjects seeking SUD treatment. Setting: Seven SUD treatment centers in a medium-sized Midwestern metropolitan area in the United States. Participants: Data from 574 SUD subjects were analyzed from a study to test interventions to improve linkage and engagement with substance abuse treatment. Measurements: Subjects completed the following preference-weighted measures: self-administered Quality of Well-Being scale (QWB-SA) and Medical Outcomes Study SF-12 (standard gamble weighted or SF-12 SG); and clinical measures: Addiction Severity Index (ASI) and a symptom checklist based on the DSM-IV. Findings: In unadjusted analyses, the QWB-SA was correlated significantly with six of seven ASI subscales and the SF-12 SG was correlated with four of seven. In adjusted analyses, both preference-weighted measures were significantly correlated with diagnostic, physical health, mental health and drug use measures, but not with legal or alcohol use measures. The QWB-SA was also correlated with employment problems and the SF-12 SG was correlated with family/social problems. Conclusions: This study generally supports the construct validity of preference-weighted health-related quality of life measures in SUD patients. However, the QWB-SA and SF-12 SG did not correlate with all ASI scales. Cost-benefit analysis may be preferable when policy-makers are interested in evaluating the full range of SUD intervention outcomes.

KW - Cost-effectiveness analysis

KW - Cost-utility analysis

KW - Health-related quality of life

KW - Quality of wellbeing scale

KW - SF-12 scale

KW - Substance use disorder

UR - http://www.scopus.com/inward/record.url?scp=47549118905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47549118905&partnerID=8YFLogxK

U2 - 10.1111/j.1360-0443.2008.02153.x

DO - 10.1111/j.1360-0443.2008.02153.x

M3 - Article

C2 - 18397359

AN - SCOPUS:47549118905

VL - 103

SP - 1320

EP - 1329

JO - Addiction

JF - Addiction

SN - 0965-2140

IS - 8

ER -